University of California San Francisco Fresno — Fresno, California

University of California San Francisco Fresno is a clinical research site located in Fresno, California, United States 93701.

Crixeo Clinical Trials Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

University of California San Francisco Fresno has participated in 36 clinical trials with 6 currently active.

Therapeutic areas: Compensated Cirrhosis, Nonalcoholic Steatohepatitis, Pulmonary Hypertension.

Sponsors: Intercept Pharmaceuticals, United Therapeutics, Conatus Pharmaceuticals Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fresno

Browse all research sites in California · View every site in Fresno

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California San Francisco Fresno?

University of California San Francisco Fresno has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California San Francisco Fresno conducted?

University of California San Francisco Fresno has 36 clinical trials on record, with 6 currently active. Their work covers Compensated Cirrhosis, Nonalcoholic Steatohepatitis, Pulmonary Hypertension.

Is University of California San Francisco Fresno accredited by Crixeo Clinical Trials?

University of California San Francisco Fresno has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California San Francisco Fresno?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.